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Abstract  
Non-communicable diseases (NCDs), including cardiovascular diseases (CVD), hypertension and 
diabetes together with HIV infection are among the major public health concerns worldwide. Health 
services for HIV and NCDs require health systems that provide for people’s chronic care needs, which 
present an opportunity to coordinate efforts and create synergies between programmes to benefit 
people living with HIV and/or AIDS and NCDs. This review included studies that reported service 
integration for HIV and/or AIDS with coronary heart diseases, chronic CVD, cerebrovascular diseases 
(stroke), hypertension or diabetes. We searched multiple databases from inception until October 
2015. Articles were screened independently by two reviewers and assessed for risk of bias. 11,057 
records were identified with 7,616 after duplicate removal. After screening titles and abstracts, 14 
papers addressing 17 distinct interventions met the inclusion criteria. We categorized integration 
models by diseases (HIV with diabetes, HIV with hypertension and diabetes, HIV with CVD and finally 
HIV with hypertension and CVD and diabetes). Models also looked at integration from micro (patient 
focused integration) to macro (system level integrations). Most reported integration of hypertension 
and diabetes with HIV and AIDS services and described multidisciplinary collaboration, shared 
protocols, and incorporating screening activities into community campaigns. Integration took place 
exclusively at the meso-level, with no micro- or macro-level integrations described. Most were 
descriptive studies, with one cohort study reporting evaluative outcomes. Several innovative 
initiatives were identified and studies showed that CVD and HIV service integration is feasible. 
Integration should build on existing protocols and use the community as a locus for advocacy and 
health services, while promoting multidisciplinary teams, including greater involvement of 
pharmacists.  There is a need for robust and well-designed studies at all levels - particularly macro-
level studies, research looking at long-term outcomes of integration, and research in a more diverse 
range of countries.   
Key Words: Integration, Cardiovascular Disease, Diabetes, Hypertension, HIV, Chronic Disease 
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Introduction 
Non-communicable diseases, including cardiovascular diseases (CVD), hypertension and diabetes 
together with HIV infection are among the leading contributors to the global burden of disease (GBD 
2013 Mortality and Causes of Death Collaborators, 2014; WHO, 2013).  The burden of CVD is greatest 
in low and middle-income countries, where treatment is largely unaffordable or unavailable (Rasha, 
McKee, Shannon, Chow, & Rangarajan, 2016; WHO, 2013; Yusuf, Wood, Ralston, & Reddy, 2015). It is 
estimated that over 700 million adults worldwide will be diagnosed with diabetes by 2025; increasingly 
and disproportionately in low and middle income countries, which lack affordable and available insulin 
and other essential medicines (NCD-RisC, 2016; WHO, 2016). HIV, despite decreases in overall new 
infections globally, remains a major threat among vulnerable groups worldwide and particularly in 
parts of Africa; nearly half of new HIV infections are people living in Nigeria, South Africa and Uganda, 
where HIV and AIDS is the number one cause of life-years lost (Collaborators, 2016; Piot, Abdool Karim, 
Hecht, & Legido-Quigley, 2015).  
 
Consequently, many countries are now coping with the dual burden of HIV and NCDs (UNAIDS, 2011). 
People living with HIV are living longer and are at greater risk of developing non-communicable 
diseases (including coronary heart disease, cervical cancer, other cancers, mental illness, kidney and 
liver disease) for various reasons, including the direct consequence of HIV infection, shared risk factors 
and side effects of HAART regimes (UNAIDS, 2011)(UNAIDS, 2011)(UNAIDS, 2011). 
Health systems, particularly in low-income countries, are often ill prepared to identify at risk patients 
and ensure life-long care (M  Rabkin, Melaku, & Bruce, 2012). However, given that HIV and non-
communicable diseases have common needs for chronic care, there is an opportunity to coordinate 
efforts and achieve synergies to benefit patients (Haregu, Setswe, Elliott, & Oldenburg, 2015). 
Although such integration is intuitively appealing, relatively little is known about the integration 
models and factors that facilitate or hinder integration in different contexts.   
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To address this gap, we systematically reviewed the literature examining programs or services 
integrating diabetes, hypertension or CVDs with HIV and AIDS, reporting outcomes where available, 
exploring barriers and facilitators to integration, and making recommendations for future research 
and policy. 
Methods 
 
This review was developed according to PRISMA guidelines (Moher, Liberati, Tetzlaff, & Altman, 2009) 
and is part of a larger systematic review of service integration for HIV and other conditions. Where 
possible, we follow the PICOS structure for study characteristics, adapted where necessary for purely 
descriptive studies. Drawing on definitions proposed by Briggs (2006), Atun et al (2010) and Legido-
Quigley et al (2013) , the concept of integration is described in Box 1 (R.  Atun, de Jongh, & Secci, 2010; 
WHO, 2008). We also drew on a dimensions of integration typology which defined service integration 
as that where different clinical services are integrated through teams or multidisciplinary professionals 
and a clinical integration as that where care is integrated into a single or coherent process within 
and/or across professionals (Curry & Ham, 2010). 
[Box 1 – about here] 
 
Inclusion criteria 
To be considered for inclusion the study should report a program that integrates HIV with CVDs and 
their risk factors (hypertension or type 2 diabetes mellitus) coronary heart disease, or cerebrovascular 
diseases (stroke). We included all studies that reported on the effects of different models of integrated 
HIV and AIDS and chronic disease services using quantitative, qualitative and mixed methods. The 
following types of studies were included: 
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 Studies that include a description or evaluation of a management or organizational change 
strategy made within an existing health system, aiming to increase integration between HIV 
and cardiovascular disease care at service delivery level. 
 Studies reporting actual integration experiences. 
 Studies reporting screening or treatment for HIV within a service targeting other chronic 
diseases or vice versa.  
 Studies describing some element of treatment. 
 Studies describing services provided in health facilities or in the community and with respect 
to any adult population.  
 Reports describing patients’ experiences or perspectives on integration of HIV with CVDs. 
 We did not exclude reports based on study design; nor did we require them to include 
outcome measures.  
 There were no date or language restrictions. Furthermore, no studies were excluded based 
on risk of bias, although this was assessed and is reported.  
 
Search strategy 
We developed a search strategy with an information specialist to be consistent with methods used by 
other authors for systematic reviews of health services integration (Box 2). The following electronic 
databases were searched from inception until October 2015: Global Health, Medline and Embase. In 
addition, the following databases were searched using a simplified search strategy to ensure 
representation from low and middle income: Cochrane library, LILACs, Africa Wide, WHOLIS and 
abstracts from the International AIDS Society (IAS) Online Resource Library from 2006 to 2015, the 
HIV Implementers meetings from 2007 to 2012 and International conferences on NCDs.  
[Box 2 – about here] 
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Search and Retrieval of Studies 
Two reviewers independently reviewed the retrieved article list to identify those relevant, based on 
title or title and abstract. Two reviewers independently assessed the retrieved articles to determine 
whether they met inclusion criteria. Any disagreements were resolved by discussion with a third 
reviewer. 
 
Data Synthesis 
Two reviewers independently extracted data from included studies using standardized forms 
developed for extracting data on study characteristics and results for both quantitative and qualitative 
studies. Differences in data extraction or interpretation of studies were resolved by discussion and 
consensus. Data were extracted from both the findings and discussion sections of the studies. The 
data were compared and any disparities resolved. Due to the heterogeneity in study design, 
intervention types, participants and outcomes, we did not conduct a meta-analysis, but instead 
present a summary of the program descriptions and results and where available report outcomes. 
 
Levels of Integration 
We defined levels and types of integration based on typologies of integrated care (Curry & Ham, 2010). 
This typology differentiated integration at the micro-level as that which focused on the patient, such 
as case management, whereas meso-level integration focused on groups or populations, such as 
screening, and macro-level involved integration of larger delivery systems. Within these levels, the 
typology distinguishes integration types; as such we classify a clinical integration as that where care is 
integrated into a single process through shared guidelines and protocols across professions and 
service integration as that where different clinical services are integrated within an organization and 
provided through multidisciplinary teams. 
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Risk of Bias Assessment 
Two reviewers independently assessed studies which present evaluative data for risk of bias using the 
Cochrane risk of bias tool for randomized studies, an adapted checklist for qualitative studies and a 
simple proforma for observational descriptive studies (Harden et al., 2001; Rees, Harden, Brunton, 
Oliver, & Oakley, 2001). This last proforma has three domains: selection bias, information bias 
(differential misclassification and non-differential misclassification) and confounding. Each domain 
was assessed as low, unclear or high. We classified studies that had a low risk of bias in all domains as 
having a low overall risk of bias. Studies that had a high or unclear risk of bias in one or more domains 
were classified as having an overall high or unclear risk of bias. 
Results 
 
11,057 records were identified with 7,616 remaining after duplicate removal. These were screened by 
title and abstract for inclusion. Of the 340 assessed for eligibility, 153 studies were included in full-text 
screening. Of these, 138 were found to be ineligible, resulting in 14 articles eligible for inclusion. These 
14 articles represent 17 studies, which met eligibility criteria for this review (Figure 1).  
[Figure 1 – about here] 
 
Models of integration 
We identified four models of integrated care defined by the conditions integrated; within these 
models integration services took place in various settings and through screening, referral and 
treatment activities, as well as through training and procedure development (Figure 2). The first model 
integrated HIV and AIDS services with diabetes (NCD-RisC, 2016; Tierney, Kimaiyo, & Mamlin, 2011; 
WHO, 2016). The second model integrated HIV and AIDS services with diabetes and hypertension 
(Chamie, Kwarisiima, Clark, Kabami, & Jain, 2012; Edwards, Bygrave, & Van Den Bergh, 2015; Kotwani, 
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Balzer, & Kwarisiima, 2014; Monroe, Rowe, Moore, & Chander, 2012; Noble, Reeves, Jackson, & 
Abrahams, 2012; Tiam, Oyebanji, & Nkonyana, 2012; UNAIDS, 2011). The third model integrated 
cardiovascular services with HIV and AIDS services (Gwarzo, Maji, & Isa-Dutse, 2012; Nyabera, Yonga, 
Mwangemi, & Bukachi, 2011; UNAIDS, 2011); and the final model described studies where HIV and 
AIDS services were integrated with diabetes, hypertension, CVD and other diseases (Inouye et al., 
2011; Namata, Kawuma, & Nakigudde, 2014; Tierney et al., 2011).   
[Figure 2 – about here] 
 
Characteristics of Included Studies 
Fourteen articles representing 17 distinct studies integrating HIV and AIDS with diabetes, hypertension 
and/or CVD met inclusion criteria (Adeyemi, Vibhakar, & Max, 2009; Bury, Stroup, Stephens, & Baker, 
2007; Chamie et al., 2012; Edwards et al., 2015; Gwarzo et al., 2012; Inouye et al., 2011; Kotwani et 
al., 2014; Monroe et al., 2012; Namata et al., 2014; Noble et al., 2012; Nyabera et al., 2011; M  Rabkin 
et al., 2012; Tiam et al., 2012; Tierney et al., 2011; UNAIDS, 2011). Six were full papers (Adeyemi et 
al., 2009; Bury et al., 2007; Chamie et al., 2012; Edwards et al., 2015; Inouye et al., 2011; Kotwani et 
al., 2014), one was a report with four case studies(UNAIDS, 2011), and seven were abstracts (Gwarzo 
et al., 2012; Monroe et al., 2012; Namata et al., 2014; Noble et al., 2012; Nyabera et al., 2011; Tiam et 
al., 2012; Tierney et al., 2011). Eleven studies were from Sub-Saharan Africa (Ethiopia, Kenya, Lesotho, 
Nigeria, South Africa Uganda), (Chamie et al., 2012; Edwards et al., 2015; Gwarzo et al., 2012; Kotwani 
et al., 2014; Namata et al., 2014; Nyabera et al., 2011; Tiam et al., 2012; Tierney et al., 2011; UNAIDS, 
2011), four from the United States (U.S.) (Adeyemi et al., 2009; Bury et al., 2007; Inouye et al., 2011; 
Monroe et al., 2012), one from the United Kingdom (U.K.) (Noble et al., 2012)and one from South-East 
Asia (Cambodia) (UNAIDS, 2011)(Figure 3).  The majority of papers were published in 2011 and 2012 
(Figure 4). Seven studies took place in community/mobile service points (Chamie et al., 2012; Inouye 
et al., 2011; Kotwani et al., 2014; Tiam et al., 2012; Tierney et al., 2011; UNAIDS, 2011); three in 
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primary health centers or general outpatient clinics (Adeyemi et al., 2009; Edwards et al., 2015; 
UNAIDS, 2011); five in HIV clinics (Bury et al., 2007; Monroe et al., 2012; Namata et al., 2014; Nyabera 
et al., 2011; UNAIDS, 2011); and two were located in secondary health facilities (Gwarzo et al., 2012; 
Noble et al., 2012) (Table 2). There was one cohort study (Bury et al., 2007). One cross-sectional study 
(Noble et al., 2012), two retrospective record reviews (Adeyemi et al., 2009; Edwards et al., 2015); one 
qualitative study (Monroe et al., 2012); and 12 program descriptions (Chamie et al., 2012; Gwarzo et 
al., 2012; Inouye et al., 2011; Kotwani et al., 2014; Namata et al., 2014; Nyabera et al., 2011; Tiam et 
al., 2012; Tierney et al., 2011; UNAIDS, 2011) (Table 3). Further, the integration types described were 
entirely at the meso-level; these include clinical and service integrations (Table 4). Integration taking 
place at the macro-level and micro-level were not reported. 
[Figure 3 – about here] 
[Figure 4 – about here] 
[Table 1 – about here] 
[Table 2 – about here] 
[Table 3 – about here] 
[Table 4 – about here] 
 
Model 1: Integrating Diabetes Services with HIV and AIDS Services  
Three studies integrated diabetes services into HIV services (Adeyemi et al., 2009; Bury et al., 2007; 
UNAIDS, 2011). Two studies examined whether goals set by the America Diabetes Association (ADA) 
were being met in an HIV clinic in the U.S. These studies involved clinicians acting as primary care 
physicians who managed HIV and other conditions, including diabetes. One case study from Ethiopia 
reported on adapting materials from an existing diabetes clinic in an HIV outpatient setting. . 
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Two examples reported clinical outcomes, assessed as meeting ADA goals; Bury et al. reported on 
diabetes treatment provision to 40 patients in an HIV clinic run by internal medicine physicians in the 
U.S., finding that most of the 40 patients achieved almost undetectable viral load and CD4 cell counts 
of 460 to 480 cells/μL and yet, less than 50% of patients achieved therapeutic goals for HbA1c, 
cholesterol, triglycerides, and blood pressure, with no statistically significant difference between 
groups receiving counselling or not (Bury et al., 2007). However, Adeyemi et al, in a retrospective 
record review providing diabetes treatment to 216 HAART patients at a large urban HIV clinic in the 
U.S., found that 54% of patients met the goal for HbA1c, 72% had HbA1c <8%, representing adequate 
control, and 151 patients (70%) had record of a complete lipid profile (Adeyemi et al., 2009). These 
figures were reported to be comparable with those achieved in general medical clinics amongst people 
who are HIV negative. The authors made several suggestions to improve outcomes, including the 
presence of a clinical pharmacist providing patient education and recommending treatment to other 
health professionals, checklists for diabetic patients, patient education targeting nutrition, care and 
diabetes and care monitoring with concomitant medications (Adeyemi et al., 2009). The case study 
from Ethiopia described adaptation of materials from an HIV clinic for use in diabetes care at a 
diabetes outpatient clinic, as well as staff training, peer training to support treatment adherence and 
patient education, and the introduction of multidisciplinary team meetings. The program reported 
that quality of care to diabetes patients living with HIV improved with an increase in the percentage 
of people receiving services; blood pressure checks (baseline = 40%, follow up = 80%), weight checks 
(baseline = <10%, follow up = >80%), fundoscopy (baseline = <10%, follow up = 50%), foot exam 
(baseline = <10%, follow up = >80%) and adherence assessments (baseline = <10%, follow up = 
>60%)(UNAIDS, 2011). 
Model 2: Integrating Hypertension and Diabetes Services with HIV and AIDS Services 
Eight studies integrated diabetes and hypertension services with HIV and AIDS services (Chamie et al., 
2012; Edwards et al., 2015; Kotwani et al., 2014; Monroe et al., 2012; Noble et al., 2012; Tiam et al., 
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2012; UNAIDS, 2011). One program description from Cambodia utilized a patient-centered case 
management approach (UNAIDS, 2011). Others from Kenya, Lesotho and Uganda reported on 
screening for HIV, hypertension and diabetes, both in mobile sites and community health campaigns 
(Chamie et al., 2012; Kotwani et al., 2014; Tiam et al., 2012). One study from the U.K. described an 
integration within a hospital hypertension clinic that offered lifestyle advice, CVD risk assessment and 
diabetes screening (Noble et al., 2012). A qualitative study, from the USA., explored patient 
perspectives on comorbidities such as diabetes and hypertension amongst HIV patients (Monroe et 
al., 2012).    
Three studies reported clinical outcomes. A program in Cambodia piloted integrated HIV, 
hypertension and diabetes care in 2 clinics, reaching 9000 patients, using a patient-centered case 
management approach, flow charts, generic medicines and routine cohort monitoring (UNAIDS, 
2011). The program reported high retention rates, increase in CD4 counts, decrease in median HbA1c 
and target blood pressure attainment amongst hypertensive patients (UNAIDS, 2011). A retrospective 
record review of 2,206 patients at an MSF clinic in Nairobi, Kenya, describes the introduction of an 
NCD program into a primary health care setting (Edwards et al., 2015).  The study found improvements 
in blood pressure and comparable diabetes outcomes among those with and without HIV; target 
systolic blood pressure was reached by 40% of those patients living with HIV and 50% of those who 
were HIV negative; target diastolic blood pressure was reached by 58% of those living with HIV as 
compared to 64.6% amongst those who were HIV negative (Edwards et al., 2015). The study also found 
comparable outcomes in diabetes patients who are HIV negative and those living with HIV; follow up 
HbA1c <7% was reached by 37.5% of those living with HIV compared to 19.6% of HIV negative patients 
(Edwards et al., 2015). A study from an in-reach hypertension clinic in the U.K. provided 36 patients 
with lifestyle advice and cardiovascular risk assessment and screening for diabetes (Noble et al., 2012). 
It reported reductions in blood pressure for most patients, with 63% achieving their target; it also 
found an average decrease in 10-year cardiovascular risk of 39% (Noble et al., 2012).  
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Other studies reported an increase in screening uptake but mixed results for subsequent referral, 
especially in mobile or community campaigns. A mobile service point screening initiative run by a 
multidisciplinary team of doctors, nurses, community workers, nutritionists, AIDS officers and 
pharmacists in Lesotho reached 8396 adults for HIV testing (Tiam et al., 2012). Among those testing 
HIV positive, 36.6% were enrolled into further HIV care; 4,434 adults underwent hypertension 
screening of whom 24.2% had elevated blood pressure and received treatment; 3,045 blood sugar 
tests were conducted, finding 3.1% participants to have elevated blood sugar and referring them on 
(Tiam et al., 2012).  Multi-day campaigns offering diagnostic, preventive, treatment and referral 
services for HIV, malaria, tuberculosis, hypertension and diabetes held in Uganda have reported 
positive results, reaching 6,300 residents or upwards of 74% of adults in the community (Chamie et 
al., 2012). Chamie et al report that among newly detected HIV cases, 39% were referred and linked to 
care, but within a subgroup with CD4 <100, 83% linked to care and started ART within 10 days; 43% of 
newly diagnosed hypertensives were linked to care and 61% of newly diagnosed diabetics (Chamie et 
al., 2012).  A different campaign from Uganda reported on a 5 day program for testing and referral to 
hypertension treatment (Kotwani et al., 2014). The study reported promising results for linkage to 
subsequent care, finding that amongst 2,252 people screened, 214 had hypertension and received 
care, 83% of these within 6 months; however, the remainder forwent follow up for various reasons 
including cost of transport and feeling better (Kotwani et al., 2014). 
One study explored patient perspectives with focus groups involving 35 patients at an HIV clinic in 
Baltimore, USA. (Monroe et al., 2012).  The study discussed barriers to treatment of comorbidities, 
reporting that patients viewed their comorbidities as a greater threat than HIV and expressed 
frustration at lack of control over them (Monroe et al., 2012). Patients also described the perceived 
ineffectiveness of medication for comorbidities and lack of clinical consequences following missed 
doses, as well as the importance of social support in adherence to medication for comorbidities and 
follow up care.  
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Model 3: Integrating CVD Services with HIV and AIDS Services 
Three studies integrated basic cardiovascular risk factor evaluation (high BMI, age and sex) with HIV 
and AIDS services. One cross sectional pilot study from Nigeria assessed the feasibility of routine 
screening for CVD risk factors in an HIV clinic (Adeyemi et al., 2009). A study from Kenya explored CVD 
care integration into HIV treatment sites through training, equipment provision and referral pathway 
establishment (Nyabera et al., 2011). Another study from Kenya briefly described in a UNAIDS report, 
sought to explore HIV and CVD service integration and reported on screening outcomes for 
hypertension amongst people living with HIV persons (UNAIDS, 2011). 
The abstract from Nigeria piloted integrating CVD screening into HIV services in a clinic with 12,177 
patients of whom 1,033 were randomly selected for screening. The study found that nearly 20% of 
those screened were identified with one or more CVD risk factor and sent for laboratory evaluation, 
concluding that CVD screening integration was feasible and necessary (Gwarzo et al., 2012). From a 
process perspective, Nyabera et al. described a program to train healthcare providers, provide 
equipment necessary for screening and to establish referral pathways in five HIV care and treatment 
sites in Kenya serving 5,786 patients (Nyabera et al., 2011). The study found that CVD service 
operationalization in an HIV setting was feasible, with staff reporting high acceptance and skills 
uptake; however, the study notes that despite successful care pathways and implementation, 1/3 of 
available CVD equipment was not in serviceable condition (Nyabera et al., 2011). A case study from 
Kenya described screening for hypertension amongst HIV infected persons and reported that persons 
living with HIV had significantly higher rates of hypertension than those who were HIV negative, 
pointing to the need for screening amongst persons living with HIV and AIDS (UNAIDS, 2011).  
Model 4: Integrating Diabetes, Hypertension and CVD Services with HIV and AIDS Services 
Three studies integrated diabetes, hypertension, CVD and other services into HIV and AIDS service 
delivery. One study sought to develop NCD specific data collection tools, standard operating 
procedures and clinician training on management of HIV-NCD comorbidity (Namata et al., 2014). One 
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abstract described a screening and referral program (Tierney et al., 2011). Another described a 
culturally sensitive social cognitive theory framework to guide self-management interventions for HIV, 
diabetes and COPD (Inouye et al., 2011). 
A study from the Mildmay Health System in Uganda, serving 10,285 clients described an integrated 
NCD program that employed new means to collect and record data (Namata et al., 2014). Using 
existing HIV structures it was possible to improve the diagnosis, tracking and management of NCDs 
within routine HIV care; of 10,285 active clients, 1,058 have been diagnosed as hypertensive, 8% of 
whom have diabetes (Namata et al., 2014). Tierney et al. reported on a community health worker led 
referral initiative in Kenya for community screening in 50 rural and urban health centers that has 
reached 454,598 persons, of whom 96% were screened for HIV, and is now expanding to provide 
hypertension and diabetes screening and expanding referral clinics to provide care for heart and lung 
disease, diabetes and other NCDs (Tierney et al., 2011). The study reports linkage with clinic-based 
care as challenging with only 17% of those referred visiting affiliated clinics; except amongst pregnant 
women where almost 90% have kept visits. A study by Inouye et al. described a culturally sensitive 
social cognitive theory framework to guide self-management interventions for HIV, diabetes and 
COPD to Asian and Pacific Island populations in Hawaii, USA. and reports developing a culturally 
appropriate strategy for HIV and NCD integrated care and stresses the importance of an 
interdisciplinary approach and collaboration in these initiatives (Inouye et al., 2011).  
Outcomes Reported 
Studies reported both clinical and descriptive outcomes (Table 4). Clinical outcomes included 
improvements in measures relating to NCDs and HIV and AIDS such as blood pressure, hemoglobin 
A1c (HbA1c), cholesterol levels and CD4 count. Descriptive outcomes included reports of process 
improvements, staff acceptance or patient satisfaction with services.  
Risk of Bias Assessment 
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We screened all studies and found only one study eligible for risk of bias assessment as it presented 
evaluative data (Bury et al., 2007). This cohort study was at moderate risk of selection bias due to 
small sample size and high performance bias due to non-blinding; other measures including detection 
bias, reporting bias and attrition bias were low or not applicable resulting in an overall moderate risk 
of bias. 
Measures of Effectiveness of Integration 
One study reported on measures of effectives of integration (Bury et al., 2007). The study included 
patients with HIV in an integrated care setting and sought to evaluate whether seeing a clinical 
pharmacist improved diabetes outcomes. There was no statistically significant difference between 
groups in attainment of ADA goals.  
 
Discussion 
 
The four models described seek to integrate HIV and AIDS services with diabetes, hypertension and/or 
CVD services through various interventions and campaigns. The first model integrates diabetes 
services into HIV and AIDS services through diabetes service provision at HIV clinics as well as through 
adaptation of HIV protocols for use in identifying and treating diabetes in a low-income HIV treatment 
setting.  The second model goes a step further and integrated care for hypertension, as well as 
diabetes and HIV and AIDS services. Most studies identified were under this model. There were 
relatively fewer studies under the third model of CVD and HIV integrations, or the fourth model, which 
integrated HIV and AIDS services with diabetes, hypertension and CVD. 
A common finding with all models was the use of existing HIV protocols and systems to both create 
NCD protocols and facilitate integration of NCD care into HIV clinics. Primarily in low-income countries 
with a high burden of HIV, these established HIV systems provide a platform for collaboration, staff 
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training and acceptance in introducing diabetes, hypertension and CVD care. Further, in these 
countries, community campaigns, health fairs and mobile service points offered scope for delivering 
screening and referral services for HIV and multiple NCDs; however, there ensues a challenge in 
ensuring referral and follow up. In high-income countries (e.g. the USA), cohort data suggest that 
integrating diabetes with HIV services is feasible, with dedicated clinical pharmacists playing an 
important role. 
These models have advantages and disadvantages (Table 5). In integrations that provide screening 
only, there is the potential to increase case detection and provide a platform for patient education on 
CVD risk factors and prevention (Tierney et al., 2011). However, screening activities require 
appropriate training, equipment, linkage to care and a supportive referral system (Namata et al., 
2014). Integrations that incorporate treatment may be better able to address patients’ multiple needs 
and can leverage on existing services, yet these integrations may introduce competing demands on 
primary care providers or exclude other NCD’s (Nyabera et al., 2011). These integrations require well 
trained staff, appropriate human resources for operationalization and culturally appropriate standard 
operating procedures and protocols to meet integrated care needs (Inouye et al., 2011). Further, there 
is a need for leadership at the service delivery level to catalyze change and drive integration of CVD, 
and other NCD’s, with HIV service provision(UNAIDS, 2011). 
[Table 5 – about here] 
Study Strengths and Limitations 
One of the strengths of our review was the inclusion of studies from a varied range of databases and 
conference archives, which served to increase the number of papers from low- and middle-income 
countries. The review also included studies published in languages other than English. A limitation of 
our review is that the majority of papers were descriptive, which although providing insightful 
knowledge on strategies and approaches, we were unable to infer the effectiveness of described 
programs. As a result, this review is highly descriptive. 
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Implications for Research 
Our review finds that the majority of research on integrating CVD, hypertension and diabetes with HIV 
and AIDS has focused on incorporating care for these conditions into existing HIV care. Studies mainly 
describe programs or interventions carried out on a small scale and in conjunction with other clinic 
activities or community campaigns. There is a need for evidence on the effectiveness of these 
integrations (including issues that facilitate or hinder integration), and for research into integrations 
occurring at the micro and macro-level.  
There is also a need for research looking at long-term outcomes and the impact of integration on HIV 
and AIDS and CVD, hypertension and diabetes. The longest follow up was 6 months. Further, there is 
a need for economic analysis, which featured in none of the studies. 
There is a growing intersection of persons with HIV and NCDs in low- and middle-income countries 
and as such there is a need for further study to evaluate the types of integrated services that are most 
effective in these countries (Yusuf et al., 2015). Thirteen of 19 studies were from sub-Saharan Africa, 
only one case report was from Asia and there were no studies from Latin America, highlighting the 
need for further research in these regions. 
The integrated approaches to NCD and HIV/ADS care resonate with the recommendation that the NCD 
movement can leverage on existing HIV and AIDS activities (Jonathan et al., 2016; M Rabkin & El-Sadr, 
2011). This includes using the community as a locus of action for activism, advocacy, accountability 
and service delivery; the importance of partnerships to facilitate multidisciplinary collaborations; as 
well as the need for evidence, data and research to evaluate advances in practice and treatment. 
Overall there is limited robust, long term and systematic evidence as to the cost and clinical 
effectiveness of HIV and CVD integration. As such there is a need to explore potential limitations of 
integrated models with well-designed studies that include long term results and evaluations. Further, 
as no papers described the use of incentives, there is need to explore if and what type would be 
appropriate and effective in facilitating greater integration of CVD and HIV services. 
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Conclusions 
Several innovative initiatives have been described for integrating CVD, hypertension and diabetes 
services with HIV and AIDS services. Many involve multidisciplinary collaboration, and integrating NCD 
care into existing HIV and AIDS services through shared and repurposed protocols, as well as 
incorporating screening activities into wider community campaigns. Further evidence on the merits of 
the different models of integration is needed using appropriate outcome measures. The need for 
robust research speaks to the greater general need for more initiatives that bring people living with 
HIV into mainstream NCD services. 
The evidence from our review shows that integration studies on HIV and CVD services are occurring 
largely in low income countries in Sub Saharan Africa and through channels that rely mainly on existing 
infrastructure used for HIV and AIDS care. The studies describe collaboration, staff education, and 
building on the existing standard operating procedures, work flows and other processes put in place 
to address the high burden of HIV and AIDS in these communities. Further development of these 
approaches could help to further disseminate integrated approached to HIV and NCD care. 
Community, mobile and HIV campaigns have also shown to be able to screen and detect risks of or 
other NCDs in people living with or at risk of NCDs; however, these programs require strong linkage 
to follow up care that is currently underdeveloped.  
As the burden of NCDs increases and persons with HIV live longer, policy makers and planners will 
need to plan for the increasing number of people with both these conditions and evaluate the best 
strategies to provide care for them.  
(Word Count: 4211) 
[Table 6 – about here] 
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Appendices 
Box 1: Definition of Integration 
 
 
 
  
Managerial or operational changes to health systems to bring together inputs, delivery, 
management and organization of particular service functions as a means of improving coverage, 
access, quality, acceptability and (cost)-effectiveness. This may include:  
 Service integrations that combine ‘different packages of services'  
 Integration of service delivery points 
 Integration at different levels of service delivery 
 Process modifications 
 Introduction of technologies aimed at aiding integration 
 Integration of management decisions 
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Box 2: Search Strategy used for Medline, Embase and Global Health via Ovid (adapted to only 
include CVD, Hypertension and Diabetes terms)  
Database: Embase <1980 to October 2015>, Global Health <1910 to October 2015>, Ovid MEDLINE(R) <1946 
to October Week 4 2015> 
1. ((vertical or horizontal or integrat* or coordinat* or co-ordinat* or link*) and (program* or care or 
service*)).mp. or delivery of health care, integrated/ or primary healthcare/  
2.  exp HIV infections/ or HIV.mp. or  Human immunodeficiency virus.mp. or "HIV/aids".mp.  
3. (All introduced in a separate line) chronic disease/ or long-term care/ or ((chronic* or persistent or long* 
term or ongoing or degenerative) adj3 (disease* or disab* or ill* or condition* or health condition* or 
medical condition*)).tw. or long* term care.tw. or (non-communicable disease* or NCD).tw. or exp diabetes 
mellitus/ or (diabetes or diabetic).tw. or exp hypertension/ or  (hypertension or high blood pressure).tw. or 
exp cerebrovascular disorders/ or  (cerebrovascular disease* or cerebrovascular disorder* or brain 
ischaemia or cerebral infarction or carotid artery disease* or stroke).tw. or exp dementia/ or (dementia or 
alzheimer*).tw. or exp epilepsy/ or epilep*.tw. or exp myocardial ischemia/ or (myocardial isch* or 
ischaemic heart disease or ischemic heart disease or angina or coronary disease* or coronary heart disease* 
or coronary artery disease* or myocardial infarction).tw. or exp heart failure/ or heart failure.tw. or exp 
obesity/ or (obesity or obese).tw. 
4. 1 and 2 and 3 
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Figure 1: Study flow diagram 
 
 
 
 
 
 
 
 
11,057 Records identified through data 
base searching  
Number of duplicates removed 3,441 
7,616 Records screened by title and abstract 
Records excluded 
(n=7,276) 
Full-text articles assessed for 
eligibility 
(n=340) 
Studies involving any NCD included 
in the review (n=153)  
 
 Full-texts and abstracts 
excluded if not involving NCDs 
Full-texts and abstracts 
excluded in not involving CVDs, 
Hypertension and Diabetes 
 (n=138)  
Articles included in the 
review (n=14)  
Studies represented in 
included articles (n=17) 
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Figure 2: Overview of Models  
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Figure 3: Map of Integrations by Model   
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Figure 4: Summary of Year of Publication for Reviewed Papers 
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Table 1:  Summary of Study Setting by Integration Model 
Integration Model Setting n= Author 
HIV and  AIDS + 
Diabetes 
HIV Facility 2  Bury et al 2007(32); 
UNAIDS 2011(9); 
Primary Health Care Centre 1 Adeyemi et al 
2009(33) 
HIV and AIDS + HT 
+ Diabetes 
 
Community/Mobile location 
4 Chamie et al 2012(22); 
Tiam et al 2012(27); 
Kotwani et al 
2014(24); UNAIDS 
2011(9) 
HIV Facility 2 UNAIDS 2011(9); 
Monroe et al 
2012(25); 
Primary Health Care Centre 1 Edwards et al 
2015(23); 
Secondary Health Care 
Centre 
1 Noble et al 2012(26) 
HIV and AIDS + 
CVD 
HIV Facility 1 Nyabera et al 
2011(29); 
Secondary Health Care 
Centre 
1 Gwarzo et al 2012(28); 
 Community 1 UNAIDS 2011(9) 
HIV and AIDS + HT 
+ CVD + Diabetes 
Community 2 Inouye et al 2011(30); 
Tierney et al 2011(21); 
Primary Health Centers 1 Namata et al 2014(31) 
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Table 2: Summary of Study Designs by Integration Model 
Integration Model Study Design n= Author 
HIV and AIDS + 
Diabetes 
Cohort Study 1 Bury et al 2007(32);  
 Retrospective Record Review 1 Adeyemi et al 
2009(33) 
Program Description 1 UNAIDS 2011(9) 
HIV and AIDS + HT 
+ Diabetes 
Program Description 5 Chamie et al 2012(22); 
Tiam et al 2012(22); 
Kotwani et al 2014; 
UNAIDS 2011(9) 
Retrospective Record Review 1 Edwards et al 
2015(30) 
Cross Sectional Study 1 Noble et al 2012(26) 
Qualitative Study 1 Monroe et al 2012(25) 
HIV and AIDS + 
CVD 
Program Description 3 Nyabera et al 
2011(29); Gwarzo et al 
2012(28); UNAIDS 
2011(9) 
HIV and AIDS + HT 
+ CVD + Diabetes 
Program Description 3 Inouye et al 2011(30); 
Tierney et al 2011(21); 
Namata et al 2014(31) 
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Table 3: Summary of Integration Types by Model 
Integration Model Integration Type n= Author 
HIV and AIDS + 
DM 
Meso – Service Integration 3 Bury et al 2007(32); 
Adeyemi et al 
2009(33); UNAIDS 
2011(9) 
HIV and AIDS + HT 
+ Diabetes 
Meso – Service Integration 7 Chamie et al 2012(22); 
Tiam et al 2012(22); 
Kotwani et al 
2014(22);  
  Edwards et al 
2015(30); Noble et al 
2012(26); Monroe et 
al 2012(25) 
 N/A 1 UNAIDS 2011(9) 
HIV and AIDS + 
CVD 
Meso - Clinical Integration 1 Gwarzo et al 2012(28) 
Meso - Service Integration 1 Nyabera et al 
2011(29) 
N/A 1 UNAIDS 2011(9) 
HIV and AIDS + HT 
+ CVD + Diabetes 
Meso - Service Integration 2 Namata et al 
2014(31); Tierney et al 
2011(21) 
Meso - Clinical integration 1 Inouye et al 2011(30) 
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Table 4: Reported outcomes by the model of integration 
Model of integration Outcome indicator reported Reported in n = 
Diabetes services 
 integrated into HIV and 
AIDS services 
Glomerular filtration rate 1 
HbA1c 2 
Blood Pressure 2 
Cholesterol level 2 
Low density lipoprotein cholesterol level 2 
Triglyceride level 2 
High density lipoprotein level 2 
Body Mass Index 2 
Descriptive outcomes 
(satisfaction/acceptance/processes) 
2 
Hypertension and Diabetes 
 integrated into HIV and 
AIDS Services 
 
HbA1c 1 
Fasting glucose 1 
Cholesterol 1 
Qualitative outcomes 1 
Provision of medication 1 
Decrease in 10 year cardiovascular risk 1 
CD4 count 2 
Blood Pressure 4 
Linkage to care 4 
Descriptive outcomes 
(satisfaction/acceptance/processes) 
4 
CVD Services integrated 
 into HIV and AIDS services 
Referral to laboratory 1 
Descriptive outcomes 
(satisfaction/acceptance/processes) 
2 
Diabetes, Hypertension and 
CVD services integrated into 
HIV and AIDS services 
Descriptive outcomes 
(satisfaction/acceptance/processes) 3 
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Table 5: Summary of advantages, disadvantages and factors impacting integration of CVD services with 
HIV/AIDS 
Advantages Disadvantages Factors 
Screening only: 
- Case detection 
- Platform for patient 
education 
- Requires adequate linkage 
to care 
- Need for adequate referral 
system and linkage to care 
- Need for adequate 
equipment to carry out 
screening 
Screening and treatment: 
- Case detection and 
monitoring 
- Addresses patients’ multiple 
needs 
- Can leverage on existing HIV 
services 
- Platform  for patient 
education 
- Improvements in blood 
pressure 
- Competing demands on 
primary care providers 
- May miss other NCDs   
- High quality training of 
clinical staff, appropriate 
human resources for mobile 
and community initiatives 
- Creation of culturally 
appropriate standard 
operating procedures and 
protocols to meet the needs 
of integrated care 
- Leadership at service 
delivery level to drive and 
implement change 
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Table 6: Summary of findings of studies examining integration of HIV with Diabetes, Hypertension and CVD 
Type of 
Integration 
Study Setting and 
Sample Size 
Study Design Integration Activities Results  Risk of 
Bias  
34 
 
HIV + 
Diabetes 
Adeyemi, 
2009 
USA-Chicago 
Primary care 
in a large, 
urban HIV 
clinic. 
n=216 
Retrospective 
Record Review 
Provide diabetes 
treatment to HAART 
patients; Comprehensive 
primary care delivered 
by the same staff. 
- HIV infected DM patients achieved ADA 
goals at rates similar to uninfected 
patients. 
- 54% of patients met the ADA goal for 
HbA1c (>7%); rate of achievement for ADA 
lipid level goals was >50% except for 
triglyceride levels (elevated triglyceride 
levels is a common complication of HAART). 
N/A 
HIV + 
Diabetes 
Bury et al, 
2007 
USA- 
Oklahoma 
HIV clinic run 
by internal 
medicine 
physicians 
n=40 
Cohort Study Provide Diabetes 
treatment to patients on 
HAART. 
- Less than 50% of patients were achieving 
goals of therapy for hemoglobin HbA1c), 
cholesterol, triglycerides, and blood 
pressure. 
- 5% were documented as receiving aspirin 
therapy. 
- The medication adherence counseling was 
not a significant factor in the results. 
Moderate 
Risk of 
Bias 
HIV + 
Diabetes 
UNAIDS 
2011 – 
case study 
in report 
Ethiopia Program 
description 
Adapting materials from 
the HIV clinic for DM 
care use in outpatient 
clinic; staff training; peer 
training for adherence 
support and education; 
multidisciplinary team 
meetings. 
- Quality of care provided to people with DM 
improved notably - including percentage of 
people receiving DM services (measuring 
BP, weight, examining eyes, feet and 
assessing adherence). 
N/A 
HIV + HT + 
Diabetes 
Chamie et 
al 2012 
Uganda – rural 
communities 
n=4343 
Program 
description 
5-day campaign offering 
diagnostic, preventive, 
treatment and referral 
services for HIV, malaria, 
TB, HT and diabetes. 
- Feasible: campaign reached 74% of adults 
in the community. 
- Identified a high burden of undiagnosed 
disease. 
- Detected HIV cases at high CD4 counts. 
N/A 
 
HIV + HT + 
Diabetes 
UNAIDS 
2011 – 
case study 
in report 
Cambodia  
n=9000 
Program 
description 
Pilot of 2 clinics for HIV, 
diabetes and 
hypertension: patient-
centered case 
management approach, 
flow charts, generic 
drugs and routine cohort 
monitoring. 
- Retention rates = 70 - 90%. 
-  Median CD4 count rose from 53 to 316 per 
mm3 at 24 months. 
- Median HbA1c of people with DM fell from 
11.5% to 8.6%. 
- 68% of people treated for HT reached 
target BP within six months. 
- No difficulties noted in terms of stigma. 
N/A 
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HIV + HT + 
Diabetes 
UNAIDS 
2011 – 
case study 
in report 
South Africa Program 
description 
South Africa plans to 
test 15 million people 
for HIV, elevated BP and 
blood sugar level. 
- N/A N/A 
HIV + HT + 
Diabetes 
Noble 
2012 
(Abstract) 
UK – in-reach 
HT clinic 
n=36 
Cross 
Sectional 
Survey 
HIV patients were given 
appropriate lifestyle 
advice, underwent full 
cardiovascular risk 
assessment and 
screening for diabetes. 
- 44% patients referred for echocardiogram, 
43% of these showed an abnormality.  
- Anti-hypertensive medications were 
introduced or changed in 85% of patients.  
- BP reduction seen in most patients 
attending the clinic with 63% achieving 
their target BP.  
- The average decrease seen in the 10-year 
cardiovascular risk was 39% with a range of 
8% to 74%.  
- All patients rated clinic as good or great on 
all aspects and were happy with the care 
they were receiving. 
N/A 
 
 
 
HIV + HT + 
Diabetes 
Kotwani 
2014 
Rural Uganda 
n=2252 
Intervention 
description 
5-day program for 
testing and referral for 
hypertension treatment. 
- 2252 adults were screened for 
hypertension and 214 hypertensive adults 
received a linkage intervention for further 
management. Of these, 178 (83%) linked to 
care within 6 months (median = 22 days). 
- Barriers for patients who did not see care 
included expensive transport (59%) and 
feeling well (59%). 
N/A 
HIV + HT + 
Diabetes 
Monroe 
2012 
(Abstract) 
USA. – 
Baltimore HIV 
Clinic 
n=35 
Qualitative (6 
focus groups) 
No integrated activities/ 
intervention. Barriers 
and facilitators elicited 
may give insight on what 
is important for an 
integrated intervention. 
- Perceptions of HIV vs. other conditions: co-
morbid conditions viewed as a greater 
threat than HIV; expressed frustration at 
not being able to control comorbidities. 
- Attitudes towards medication: perceived 
ineffectiveness of medications for 
comorbidities and lack of clinical 
consequences of missed doses.  
- Acceptance of HIV and integration of 
multiple diagnoses into daily life: 
importance of social support in medication 
adherence and use of various reminder 
systems. 
N/A 
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HIV + HT + 
Diabetes 
Edwards 
2015 
Kiberia, 
Nairobi, Kenya 
– MSF clinic 
n=2206 
Descriptive 
study: 
Retrospective 
Record Review  
NCD chronic disease 
health care package 
offered at clinic - 
compared those PLHIV 
and those without who 
presented with 
hypertension and/or DM 
and were enrolled in the 
NCD package. 
- For those with hypertension - 
improvements in blood pressure regardless 
of HIV status - target SBP reached by 40% 
PLHIV and 50% for HIV negative, target DBP 
reached by 58% PLHIV and 64.6% HIV 
negative.  
- Comparable outcomes for DM patients - 
follow up HbA1c <7% reached by 37.5% for 
PLHIV and 19.6% for HIV-negative patients. 
N/A 
HIV + HT + 
Diabetes 
Tiam 2012 
(Abstract) 
Rural Lesotho 
– mobile 
service 
delivery points 
Program 
description 
Integrated health 
services provided at 
mobile service delivery 
points in rural settings 
staffed by multi-
disciplinary teams of 
doctors, nurses, 
community workers, 
nutritionists, AIDS 
officers and 
pharmacists. 
- 8,396 adults were tested for HIV (67.3% 
female; 32.6% male). 588 (7%) tested HIV-
positive (6.7% female; 7.1% male).  
- 4,454 adults (24.7% male; 75.3% female) 
were screened for hypertension, and of 
those screened, 24.2% had elevated BP and 
linked to care centers. 3,045 adults had 
blood sugar tests (27.0% males; 73.0% 
females); 3.1% had elevated blood sugar 
and linked to care. 
N/A 
HIV +CVD UNAIDS 
2011 - 
case study 
in report 
Kenya Descriptive Screening for HT 
amongst HIV infected 
persons. 
- When people were screened for both HIV 
infection and NCD, HIV positive people had 
significantly higher rates of hypertension 
than those who were HIV negative. 
N/A 
HIV + CVD Nyabera 
2011 
(Abstract) 
Kenya – 5 HIV 
care and 
treatment 
sites 
n=5786 
Descriptive 
report 
Training of healthcare 
providers, provision of 
equipment for basic 
evaluation of 
cardiovascular risk 
factors and common 
CVDs, establishment of 
referral pathways for 
specialist treatment.  
- Counselling and clinician consultation 
services easily integrated and high staff 
skills uptake acceptance.  
- Care pathways adequately implemented in 
all sites but 1/3 of CVD equipment not in 
serviceable condition.  
- Overall, integration of CVD screening and 
management into routine HIV care is 
feasible. 
N/A 
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HIV+ CVD Gwarzo et 
al, 2012 
(Abstract) 
Nigeria-
secondary 
health facility 
n=1033 
Descriptive 
study 
Targeted CVD screening 
for PLHA and referral to 
an on-site cardiac clinic. 
- 205 (19.8%) of 1033 screened had one or 
more CVD risk factors; 42% of whom had a 
CVD risk of < 20%, and 2.4% a CVD risk of 
≥20%. 
- The most common risk factors identified 
were age (25.7%), male sex (25.9%), high 
BMI (21.8%), and hypertension (15.2%). 
N/A 
HIV + DM + 
HT + CVD 
Namata 
2014 
Uganda – 
Mildmay 
health system  
n=10285 
clients 
Program 
description 
Development of: NCD 
specific data collection 
tools; SOPs for NCD 
diagnosis and 
management; Medical 
records/ files for HIV 
positive clients with HT 
or other NCDs have 
been tagged and 
clinicians sensitized on 
management of HIV- 
NCD co-morbidity. 
- The existing HIV care and treatment 
infrastructure provides a viable platform 
for screening and managing NCD especially 
for a population aging with HIV.  
- Improvement in diagnosis, tracking and 
management of NCDs, particularly 
Hypertension, diabetes, cardiovascular 
disease and mental health as part of 
routine HIV care. 
 
N/A 
HIV + DM + 
HT + 
Others 
Tierney et 
al 2011 
(Abstract) 
Kenya – 50 
rural and 
urban health 
centers 
Program 
description 
Community health 
workers refer patients 
with HIV and other 
diseases to clinics 
through home 
counselling and testing  
- Screening has been successful and will roll 
out HT and DM screening but referral to 
clinic for treatment/monitoring has been 
challenging; success amongst pregnant 
women. 
-  HCT counsellors outreach = 454,598 
persons; 98% agreed to HCT interview; HIV 
and TB screening = 96%; clinic visits = 17% 
kept visits; clinic visits amongst pregnant 
women = >90% kept visits. 
N/A 
HIV + DM + 
COPD 
Inouye 
2011 
USA - Hawai’i 
Primary Health 
Care settings 
& community 
site 
Intervention 
description 
Culturally sensitive social 
cognitive theory 
framework to guide self-
management 
interventions to Asian 
and Pacific Island 
populations. 
- Framework for using social cognitive theory 
to support self-management interventions; 
paper reports the experience of developing 
an interdisciplinary research center focused 
on self-management of chronic conditions 
- Highlights the interdisciplinary approach 
and collaboration needed for integrated 
initiatives. 
N/A 
38 
 
Figure and Table Captions List 
Box 1: Definition of Integration 
Box 2: Search Strategy used for Medline, Embase and Global Health via Ovid  
Figure 1: Study flow diagram 
Figure 2: Overview of Models  
Figure 3: Map of Integrations by Model   
Figure 4: Summary of Year of Publication for Reviewed Papers 
Table 1:  Summary of Study Setting by Integration Model 
Table 2: Summary of Study Designs by Integration Model 
Table 3: Summary of Integration Types by Model 
Table 4: Reported outcomes by the model of integration 
Table 5: Summary of advantages, disadvantages and factors impacting integration of CVD services with 
HIV/AIDS 
Table 6: Summary of findings of studies examining integration of HIV with Diabetes, Hypertension and 
CVD 
 
 
